CIK: 1405253 - Address: C/O Tarsus Pharmaceuticals, Inc., 15440 Laguna Canyon Road, Suite 160, Irvine, CA 92618
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
3/20/25 21:48
3/18/25
TARSTarsus Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagFarrow Jeffrey SCAOSee RemaS.m-17847.880-4-1422D
3/18/25 21:40
3/15/25
TARSTarsus Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagFarrow Jeffrey SCAOSee RemaM.d00.00084426D
6/20/24 16:26
6/17/24
TARSTarsus Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagFarrow Jeffrey SCAOSee RemaM.d00.0002818D
6/20/24 16:26
6/18/24
TARSTarsus Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagFarrow Jeffrey SCAOSee RemaS.d-28727.470-10-3718D
9/29/22 20:48
9/27/22
GBTGlobal Blood Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsFarrow Jeffrey SCAOCFOM.d38816.4002476627D
9/6/22 19:00
9/1/22
GBTGlobal Blood Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsFarrow Jeffrey SCAOCFOM.d00.00053D
9/6/22 19:00
9/1/22
GBTGlobal Blood Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsFarrow Jeffrey SCAOCFOS.d-2,13868.000-31-913D
8/3/22 18:00
8/1/22
GBTGlobal Blood Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsFarrow Jeffrey SCAOCFOM.d00.00062431D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact